FDA highlights concerns with compounding of drug products by medical offices and clinics under insanitary conditions

Human drug compounding is generally a practice in which ingredients of a drug are combined, mixed, or altered to create a medication tailored to the medical needs of an individual patient. Section 503A of the Federal Food, Drug and Cosmetic Act (FD&C Act) describes the conditions under which compoun

Source: FDA Center for Drug Evaluation and Research - What's New - October 25, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news